Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$70.46
0.851.22%
al cierre: -
$70.52
0.060.09%
After hour: Oct 24, 7:42 PM EDT
Comments
Loading...
Calificaciones de analistas, precios objetivo, pronóstico
Abercrombie & Fitch Co ha un obiettivo di prezzo di consenso pari a $116.77, stabilito in base alle ultime valutazioni degli analisti di 14. Le ultime 3 valutazioni degli analisti sono state rilasciate da JP Morgan, BTIG y Telsey Advisory Group il octubre 6, 2025, septiembre 18, 2025 y septiembre 12, 2025. Con un obiettivo di prezzo medio di $116 tra le JP Morgan, BTIG y Telsey Advisory Group, c'è un implicito 64.49% upside per Abercrombie & Fitch Co da queste valutazioni degli analisti.
Firmas de analistas que realizan recomendaciones1
JP Morgan
BTIG
Telsey Advisory Group
Citigroup
Raymond James
1calculado a partir de las calificaciones de los analistas
Calificaciones de analistas para Abercrombie & Fitch
Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
10/06/2025 | 46.06% | JP Morgan | → $103 | Downgrade | Overweight → Neutral | |||
09/18/2025 | 70.16% | BTIG | → $120 | Initiates | → Buy | |||
09/12/2025 | 77.25% | Telsey Advisory Group | $125 → $125 | Maintains | Outperform | |||
08/28/2025 | 105.62% | JP Morgan | $151 → $145 | Maintains | Overweight | |||
08/28/2025 | 77.25% | Telsey Advisory Group | $125 → $125 | Maintains | Outperform | |||
08/27/2025 | 77.25% | Telsey Advisory Group | $125 → $125 | Maintains | Outperform | |||
08/20/2025 | 77.25% | Telsey Advisory Group | $125 → $125 | Maintains | Outperform | |||
08/20/2025 | 48.89% | Citigroup | → $105 | Downgrade | Buy → Neutral | |||
07/28/2025 | 114.12% | JP Morgan | $141 → $151 | Maintains | Overweight | |||
06/16/2025 | 99.94% | JP Morgan | $147 → $141 | Maintains | Overweight | |||
05/29/2025 | 40.39% | Raymond James | $90 → $99 | Maintains | Outperform | |||
05/29/2025 | 16.28% | Morgan Stanley | $78 → $82 | Maintains | Equal-Weight | |||
05/29/2025 | 19.12% | Barclays | $71 → $84 | Maintains | Equal-Weight | |||
05/29/2025 | 108.45% | JP Morgan | $142 → $147 | Maintains | Overweight | |||
05/29/2025 | 77.25% | Telsey Advisory Group | $125 → $125 | Maintains | Outperform | |||
05/28/2025 | 77.25% | Telsey Advisory Group | $125 → $125 | Maintains | Outperform | |||
05/27/2025 | 27.62% | Raymond James | $110 → $90 | Maintains | Outperform | |||
05/21/2025 | 91.44% | Jefferies | $170 → $135 | Maintains | Buy | |||
05/19/2025 | 101.36% | JP Morgan | $155 → $142 | Maintains | Overweight | |||
05/19/2025 | 84.34% | UBS | $115 → $130 | Maintains | Buy | |||
05/06/2025 | 10.61% | Morgan Stanley | $114 → $78 | Maintains | Equal-Weight | |||
04/21/2025 | 0.68% | Barclays | → $71 | Initiates | → Equal-Weight | |||
04/14/2025 | 119.8% | JP Morgan | $168 → $155 | Maintains | Overweight | |||
04/08/2025 | 38.97% | Citigroup | $135 → $98 | Maintains | Buy | |||
03/06/2025 | 55.98% | Raymond James | $124 → $110 | Maintains | Outperform | |||
03/06/2025 | 112.71% | UBS | $210 → $150 | Maintains | Buy | |||
03/06/2025 | 91.44% | Citigroup | $160 → $135 | Maintains | Buy | |||
03/06/2025 | 77.25% | Telsey Advisory Group | $190 → $125 | Maintains | Outperform | |||
03/05/2025 | 138.23% | JP Morgan | $189 → $168 | Maintains | Overweight | |||
03/05/2025 | 141.07% | Jefferies | $220 → $170 | Maintains | Buy | |||
02/26/2025 | 169.43% | Telsey Advisory Group | $190 → $190 | Maintains | Outperform | |||
02/24/2025 | 197.79% | UBS | $220 → $210 | Maintains | Buy | |||
01/15/2025 | 97.11% | Morgan Stanley | $149 → $139 | Maintains | Equal-Weight | |||
01/14/2025 | 133.98% | Raymond James | $180 → $165 | Maintains | Outperform | |||
01/14/2025 | 169.43% | Telsey Advisory Group | $190 → $190 | Maintains | Outperform | |||
01/10/2025 | 211.97% | UBS | $173 → $220 | Upgrade | Neutral → Buy | |||
12/20/2024 | 189.28% | JP Morgan | $201 → $204 | Maintains | Overweight | |||
12/06/2024 | 155.25% | Raymond James | → $180 | Initiates | → Outperform | |||
11/27/2024 | 145.32% | UBS | $170 → $173 | Maintains | Neutral | |||
11/27/2024 | 111.29% | Morgan Stanley | $147 → $149 | Maintains | Equal-Weight | |||
11/26/2024 | 169.43% | Telsey Advisory Group | $190 → $190 | Maintains | Outperform | |||
11/14/2024 | 141.07% | UBS | $165 → $170 | Maintains | Neutral | |||
10/04/2024 | 176.52% | JP Morgan | $194 → $195 | Maintains | Overweight | |||
09/11/2024 | 169.43% | Telsey Advisory Group | $190 → $190 | Maintains | Outperform | |||
09/04/2024 | 211.97% | Jefferies | $215 → $220 | Maintains | Buy | |||
08/30/2024 | 169.43% | Citigroup | → $190 | Upgrade | Neutral → Buy | |||
08/29/2024 | 108.45% | Morgan Stanley | $155 → $147 | Maintains | Equal-Weight | |||
08/29/2024 | 133.98% | UBS | $193 → $165 | Maintains | Neutral | |||
08/28/2024 | 194.95% | Telsey Advisory Group | $208 → $208 | Maintains | Outperform | |||
08/21/2024 | 194.95% | Telsey Advisory Group | $208 → $208 | Maintains | Outperform | |||
07/22/2024 | 175.1% | JP Morgan | $167 → $194 | Upgrade | Neutral → Overweight | |||
07/11/2024 | — | Argus Research | — | Downgrade | Buy → Hold | |||
05/30/2024 | 169.43% | Citigroup | $150 → $190 | Maintains | Neutral | |||
05/30/2024 | 173.68% | UBS | $155 → $193 | Maintains | Neutral | |||
05/30/2024 | 143.9% | Morgan Stanley | $112 → $172 | Maintains | Equal-Weight | |||
05/30/2024 | 194.95% | Telsey Advisory Group | $152 → $208 | Maintains | Outperform | |||
05/29/2024 | 136.81% | JP Morgan | $144 → $167 | Maintains | Neutral | |||
05/29/2024 | 204.88% | Jefferies | $155 → $215 | Maintains | Buy | |||
05/29/2024 | 115.54% | Telsey Advisory Group | $152 → $152 | Maintains | Outperform | |||
05/23/2024 | 115.54% | Telsey Advisory Group | $152 → $152 | Maintains | Outperform | |||
05/21/2024 | 112.71% | Citigroup | $140 → $150 | Maintains | Neutral | |||
05/21/2024 | 119.8% | UBS | $145 → $155 | Maintains | Neutral | |||
05/17/2024 | 104.2% | JP Morgan | $125 → $144 | Maintains | Neutral | |||
05/06/2024 | 58.82% | Morgan Stanley | $103 → $112 | Maintains | Equal-Weight | |||
04/11/2024 | 84.34% | Argus Research | $97 → $130 | Maintains | Buy | |||
03/07/2024 | 98.53% | Citigroup | $127 → $140 | Maintains | Neutral | |||
03/07/2024 | 46.06% | Morgan Stanley | $81 → $103 | Maintains | Equal-Weight | |||
03/07/2024 | 115.54% | Telsey Advisory Group | $140 → $152 | Maintains | Outperform | |||
03/06/2024 | 98.53% | Telsey Advisory Group | $140 → $140 | Reiterates | Outperform → Outperform | |||
03/06/2024 | 119.8% | Jefferies | $149 → $155 | Maintains | Buy | |||
02/28/2024 | 98.53% | Telsey Advisory Group | — | $105 → $140 | Maintains | Outperform | ||
02/27/2024 | 80.09% | Citigroup | $100 → $127 | Maintains | Neutral | |||
02/26/2024 | 84.34% | UBS | $98 → $130 | Maintains | Neutral | |||
01/09/2024 | 41.8% | Citigroup | $82 → $100 | Maintains | Neutral | |||
01/09/2024 | 48.89% | Telsey Advisory Group | $95 → $105 | Maintains | Outperform | |||
01/09/2024 | 38.97% | UBS | $93 → $98 | Maintains | Neutral | |||
11/22/2023 | 16.28% | Citigroup | $75 → $82 | Maintains | Neutral | |||
11/22/2023 | 6.35% | UBS | $70 → $75 | Maintains | Neutral | |||
11/22/2023 | -3.57% | Morgan Stanley | $53 → $68 | Maintains | Equal-Weight | |||
11/22/2023 | 17.7% | Telsey Advisory Group | $74 → $83 | Maintains | Outperform | |||
11/21/2023 | 4.93% | Telsey Advisory Group | $74 → $74 | Reiterates | Outperform → Outperform | |||
11/14/2023 | 4.93% | Telsey Advisory Group | $62 → $74 | Maintains | Outperform | |||
11/13/2023 | -0.74% | UBS | $53 → $70 | Maintains | Neutral | |||
09/07/2023 | -12.08% | Telsey Advisory Group | $56 → $62 | Maintains | Outperform | |||
08/25/2023 | -27.68% | Morgan Stanley | $18 → $51 | Upgrade | Underweight → Equal-Weight | |||
08/24/2023 | -12.08% | JP Morgan | $45 → $62 | Maintains | Neutral | |||
08/24/2023 | -24.84% | UBS | $42 → $53 | Maintains | Neutral | |||
08/24/2023 | -20.59% | Telsey Advisory Group | $47 → $56 | Maintains | Outperform | |||
08/23/2023 | -33.35% | Telsey Advisory Group | $47 → $47 | Reiterates | Outperform → Outperform | |||
08/16/2023 | -33.35% | Telsey Advisory Group | $35 → $47 | Maintains | Outperform | |||
08/15/2023 | -36.19% | Citigroup | $33 → $45 | Maintains | Neutral | |||
06/12/2023 | -41.86% | Argus Research | → $41 | Upgrade | Hold → Buy | |||
05/25/2023 | -74.48% | Morgan Stanley | $17 → $18 | Maintains | Underweight | |||
05/25/2023 | -53.2% | Citigroup | $24 → $33 | Maintains | Neutral | |||
05/25/2023 | -54.62% | UBS | $28 → $32 | Maintains | Neutral | |||
05/25/2023 | -50.37% | Telsey Advisory Group | → $35 | Reiterates | Outperform → Outperform | |||
05/24/2023 | -50.37% | Telsey Advisory Group | → $35 | Reiterates | Outperform → Outperform | |||
05/18/2023 | -65.97% | Citigroup | $32 → $24 | Maintains | Neutral | |||
05/17/2023 | -50.37% | Telsey Advisory Group | → $35 | Reiterates | Outperform → Outperform | |||
05/09/2023 | -57.46% | Jefferies | $35 → $30 | Maintains | Buy |
PREGUNTAS FRECUENTES
¿Cuál es el precio objetivo de las acciones de Abercrombie & Fitch (ANF)?
El último precio objetivo de Abercrombie & Fitch (NYSE:ANF) fue comunicado por JP Morgan el octubre 6, 2025. La firma de analistas fijó un precio objetivo para $103.00 que espera ANF a rise dentro de 12 meses (un posible 46.06% upside). 42 firmas de analistas han reportado calificaciones en el último año.
¿Cuál es la calificación más reciente de los analistas sobre Abercrombie & Fitch (ANF)?
La última calificación de analistas para Abercrombie & Fitch (NYSE:ANF) fue proporcionada por JP Morgan, y Abercrombie & Fitch rebajado su neutral calificación.
¿Cuándo se produjo la última revisión al alza de Abercrombie & Fitch (ANF)?
La última revisión al alza de Abercrombie & Fitch Co se produjo en enero 10, 2025, cuando UBS elevó su precio objetivo a $220. UBS anteriormente tenía a neutral para Abercrombie & Fitch Co.
¿Cuándo fue la última revisión a la baja de Abercrombie & Fitch (ANF)?
La última revisión a la baja de Abercrombie & Fitch Co se produjo en octubre 6, 2025, cuando JP Morgan cambió su precio objetivo de N/A a $103 para Abercrombie & Fitch Co.
¿Cuándo se publicará o actualizará la próxima calificación de los analistas para Abercrombie & Fitch (ANF)?
Los analistas llegan a las calificaciones de acciones después de hacer una investigación exhaustiva, que incluye revisar los estados financieros públicos, hablar con ejecutivos y clientes de Abercrombie & Fitch, y escuchar las teleconferencias de ganancias. La mayoría de los analistas hacen esto cada tres meses, por lo que deberías recibir 4 calificaciones por empresa al año. La última calificación de Abercrombie & Fitch se registró el octubre 6, 2025, por lo que la próxima calificación estará disponible en torno al octubre 6, 2026.
¿Es correcta la calificación de los analistas sobre Abercrombie & Fitch (ANF)?
Aunque las calificaciones son subjetivas y pueden cambiar, la última calificación de Abercrombie & Fitch (ANF) fue un rebajado con un precio objetivo de $0.00 a $103.00. El precio actual al que cotiza Abercrombie & Fitch (ANF) es de $70.52, que es within del rango previsto por el analista.
Explora calificaciones de analistas y precios objetivo sobre todos los valores.